BridgeBio have demonstrably improved the progress of an novel treatment for ATTR-CM, utilizing the compound. Preliminary trial results indicates promising benefits for those affected from a debilitating disease. This https://bridgebio529214.targetblogs.com/42432087/bridgebio-improves-attr-cm-management-with-attruby